Hamps Bio Limited

₹25.50As of Sun 8 Nov 2026, 12:00 UTC
BSE:544312Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (4.03%)
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM (1.89%)
Mkt cap ₹222.2M
ROIC (3.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹25
(0.91%)
(85.09%)
Hold 3|5|5|12|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.37
0.40
0.39
0.39
21.89%
28.58%
18.70%
12.33%
Revenue₹M
15.77
16.00
16.12
16.27
5.90%
5.95%
5.13%
5.91%
Peers (US$2.366M)
Cap (US$)
PE
3.016M
11.78x
2.435M
9.419x
Capital
TTM
5Y
10Y
Leveragex
6.294
0.204
0.169
EBIT/Intx
2.397
0.138
0.126
Own earn%
16.52
38.83
30.82
Sh yield%
37.81
23.38
24.22
Owners
Insiders/Inst%
12.90
64.44
Short interest%
2.24
SBC / revenue%
5.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
14–19
$1 testx
—
Incr. ROIC%
15